Skip to main content

Stonegate Initiates Coverage on Sirona Biochem Corp (TSX-V:SBM)

DALLAS - (NewMediaWire) - October 17, 2024 - Sirona Biochem Crop (TSX-V:SBM): Stonegate Capital Partners initiates their coverage on Sirona Biochem Corp (TSX-V:SBM).

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • GlycoProteMim™ is a potential standout in the premium skincare market
  • Sirona is targeting profitability by 2025, with expected revenue from Allergan Aesthetic and the commercialization of GlycoProteMim™ set to drive growth.
  • Sirona’s partnerships place it in a strong position to capture market share in the growing global skincare industry.

Click image above to view full announcement.

About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.29
+4.84 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.16
+1.35 (0.74%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.